drugset / Trial / NCT01962233

Umbilical Cord Derived Mesenchymal Stem Cells Therapy in Hypoxic Ischemic Encephalopathy

NCT01962233

Phase 1 Unknown 10 enrolled Hebei Medical University
NaSingle-groupOpen-labelTreatment

Summary

This study is to evaluate the safety and efficacy of Umbilical Cord Derived Mesenchymal Stem Cells transplantation in hypoxic ischemic encephalopathy.

Timeline

Start
2013-09
Primary completion
2013-12
Completion
2014-12

Drugs

EvaluationDrugModalityDoseRoute
Subject mesenchymal stem cells Cell therapy 1e+08 cells Intravenous
Subject mesenchymal stem cells Cell therapy 8e+08 cells Intravenous